Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Ketorolac vs Diclofenac for Postoperative Pain in Irreversible Pulpitis
NCT03116672Completed
- Sponsor
- Universidad Autónoma de Baja California
- Start
- Feb 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketorolac in irreversible pulpitis and apical periodontitis (AP) (3 arms), sponsored by Universidad Autónoma de Baja California. Primary endpoint: Level of post operative pain at 1 year. Started Feb 2016; status: completed.
02
Drugs
ketorolac
03
Conditions
irreversible pulpitisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT03116672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03116672.